FDA Investigator Lucila B Nwatu

Lucila B Nwatu has inspections in 7 countries as of 13 Oct 2023. Lucila B Nwatu has collaborated with a combinined 4763 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
59
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Germany, France, India, Korea (Republic of), Italy
Co-Investigator(s):
Abby E Pelletier, Alan P Kurtzberg, Alex G Kalugin, Alexis R Ajello, Alice A Blair, Alice S Tsao, Alicia M Mozzachio, Alla Dubrovsky, Amir Alavi, Anastasia I Onuorah, Anastasia M Shields, Andrei Perlloni, Andrew E Kay, Andrew K Haack, PhD, Andrew T Todd, Angel K Sandhu, Angela D Wise, Anh M Lac, Anita Narula, PhD, Ann L Demarco, Anna L Marroquin, Anna L Viveros Hernandez, Arsen Karapetyan, Ashar P Parikh, Avery J Dennis, Baker, Benny Y Gong, Bo Chi, PhD, Carl Lee, Carolyn A Renshaw, Carr, Carrie A Hughes, Caryn M Mcnab, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Celeste K Wong, Charles L Zhou, Chengjiu Hu, Chloe Anne Leong, Christopher J Lee, Christopher R Czajka, Claire M Minden, Courtney R Bolton, Cynthia Jim, CSO, Damon A Growl, Daniel J Roberts, Darlene B Almogela, Darren S Brown, David A Lum, David G Eng, Deborah Schmiel, PhD, Debra D Devlieger, Debra I Love, Dennis Cantellops Paite, Devaughn Edwards, Diane L Raccasi, Dogbeda F Mackenzie, Dr. Barbara D Paul, PhD, Dr. Monica D Cooper, Dr. Ralph M Bernstein, PhD, Dustin P Tran, Dustin R Abaonza, Eileen A Liu, Elisabeth A Drevet, Elizabeth Juarez, Emal Wahab, Eric C Nielsen, Eric L Dong, BS, Erica R Pomeroy, Estefania Fernandez, Felix Maldonado, Foley, Frank P Bianco, Gabrielle J Swain, George J Flynn, Glen E Harelson, Guerlain Ulysse, Gunneet Kaur, Gwyn G Dickinson, Helen J Hamaoka, Henry K Lau, Humberto Z Gomez, Hyung Yul Lee, Ingrid A Zambrana, Ismael Garibay, Jacek Cieslak, PhD, James A Lane, James C Lee, PharmD, James R Birkenstamm, James R Evans, Janice R Small, Janice Wai, Jeanmaire Hryshko, Jeanne J Thai, Jeannie Pradyanata, Jeffrey M Watson, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer L Degroot, Jennifer L Johnson, Jenny K Yee, Jessica B Darneille, Joan T Briones, John A Gonzalez, John A Liu, Jolanna A Norton, Jolene S Hedgecock, Jose Acruz Gonzalez, Joseph A Seitz, Joseph Kutze, PhD, Joseph M Willems, Juan A Morales, Juanita P Versace, Jude C Dikes, Justin A Boyd, Kacie M Crowther, Karen D Phung, Karla J Gibler, Katherine Szestypalow, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kendra A Biddick, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Lance M De Souza, MBA, Larkin R Buckalew, Larry K Austin, Laurel A Beer, Laurie Graham, LCDR Jennifer H Rhyu, Lee, Leongc, Linan Ha, PhD, Linda F Murphy, Linda Linh T Nguyen, Linda Thai, Liu, Lydia S Chan, Lynda L Perry, PhD, Macropolk, Madushini Dharmasena, PhD, Maida Henesian (NMI), Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Maridali De Leon Torres, Marion Michaelis, Marissa J Chan, Mariza M Jafary, Mark E Baldwin, Mark E Chan, Mark I Nakano, Marshalette Edwards, Marshalette O Edwards, Mary C Acton, Mary R Hole, Matthew A Walburger, Matthew B Casale, Matthew R Clabeaux, Megan E Kulas, Mei Chiung J Huang, Melody M Ragasa Leong, Michael D Kawalek, Michael O Skidmore, Michael Shanks, MS, Michele L Obert, Michelle L Tripp, Michelle Rfrazier Jessen, PhD, Miguel A Martinez, Mihaly S Ligmond, Milos Dokmanovic, PhD, Monica Markovski, PhD, Nancy E Boocker, Narong Chamkasem, PhD, Natalia Pripuzova, PhD, Nayan J Patel, Neil J Bonzagni, PhD MPH, Nicholas L Hunt, Nicole Yuen, Nympha V Florendo, Omotunde O Osunsanmi, Paraluman S Leonin, Patricia F Hughes, PhD, Patrick J Lynch, Paula A Trost, Peter E Baker, Phillip Angart, PhD, Phung, Prabhu P Raju, Qing Joanna Zhou, PhD, Ramon A Hernandez, Randall J Plunkett, Randy L Elsberry, Raphael E Brykman, Ravi S Harapanhalli, Raymond T Oji, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richmond K Yip, Riley C Graham, Riley C Myers, PhD, Rita K Kabaso, Robert D Tollefsen, Roger D Gawne, Roger F Zabinski, Rumany C Penn, PharmD, Ruth Moore, PhD, Samina S Khan, Sandra A Hughes, Sandra S Saniga, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sarah Arden, Sarah Kennett, PhD, Scott N Lim, Scott T Ballard, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Siobhan A Gallagher, State Agency, Stephanie A Slater, MS, Stephen D Brown, Steven A Gonzales, Steven B Chiu, Steven Fong, MS, PhD, Steven M Galvez, Steven P Donald, Stuart W Russell, Taichun Qin, PhD, Terrance P Nguyen, Terrence Gee, Terry A Hook, DPh, Thea C Grome, Thomas J Arista, Thomas N Adjabeng, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiffany Chao, Timothy T Kapsala, Tonia F Bernard, Torrance J Slayton, Travelle D Mason, Tristian E Strait, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vebina K Sethi, Vibhakar J Shah, PhD, Victoria Taylor, Vilmary Negron Rodriguez, Virginia Carroll, PhD, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, Wayne L Jefferson, William J Weis, William V Millar, Yasamin Ameri, Yong Hu, Yumi J Hiramine, Yun Wu, PhD, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Lucila B Nwatu's Documents

Publish Date Document Type Title
February, 2017 FDA 483 Nordmark Pharma GmbH - Form 483, 2017-02-17
May, 2016 EIR Impax Laboratories, LLC. - EIR, 2016-05-04
June, 2018 FDA 483 Samsung Biologics Co., Ltd. - Form 483, 2018-06-26
September, 2017 FDA 483 COSMECCA KOREA CO., LTD - Form 483, 2017-09-22
November, 2016 FDA 483 Assertio Therapeutics, Inc. - Form 483, 2016-11-02
March, 2018 FDA 483 One Way Drug DBA Partell Specialty Pharmacy - Form 483, 2018-03-08
August, 2018 FDA 483 Genentech, Inc. - Form 483, 2018-08-22
February, 2019 EIR SOFIE Co. dba SOFIE - EIR, 2019-02-05
September, 2016 EIR Actelion Pharmaceuticals U.S., Inc. - EIR, 2016-09-21
November, 2017 FDA 483 Intersect ENT, INC. - Form 483, 2017-11-03
May, 2017 EIR CSBio Co. - EIR, 2017-05-12
May, 2016 FDA 483 Response Impax Laboratories, LLC. - Form 483R, 2016-05-25
May, 2018 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2018-05-25
June, 2018 FDA 483 Hanmi Fine Chemical Co., Ltd. - Form 483, 2018-06-15
May, 2017 FDA 483 CSBio Co. - Form 483, 2017-05-12
May, 2015 FDA 483 Response Impax Laboratories, LLC. - Form 483R, 2015-06-01
June, 2016 FDA 483 Amneal Oncology Private Limited - Form 483, 2016-06-08
March, 2019 FDA 483 K & D Laboratories, Inc. dba Purity Laboratories, Inc. - Form 483, 2019-03-15
January, 2015 FDA 483 AnazaoHealth Corporation - Form 483, 2015-01-30
May, 2016 FDA 483 Impax Laboratories, LLC. - Form 483, 2016-05-04
December, 2015 FDA 483 CSBio Co. - Form 483, 2015-12-07
May, 2015 FDA 483 Impax Laboratories, LLC. - Form 483, 2015-05-08
July, 2022 FDA 483 INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483, 2022-07-01
December, 2015 EIR CSBio Co. - EIR, 2015-12-07
December, 2015 FDA 483 Acorn NMR Inc. - Form 483, 2015-12-11
August, 2016 FDA 483 Raptor Pharmaceuticals Inc. - Form 483, 2016-08-24
February, 2018 EIR ALZA Corporation - EIR, 2018-02-01
September, 2016 FDA 483 Actelion Pharmaceuticals U.S., Inc. - Form 483, 2016-09-21
November, 2017 FDA 483 Response Intersect ENT, INC. - Form 483R, 2017-11-28
February, 2018 FDA 483 ALZA Corporation - Form 483, 2018-02-01
March, 2015 FDA 483 Columbia Cosmetics Manufacturing, Inc. - Form 483, 2015-03-27
July, 2015 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2015-07-17
May, 2015 EIR Impax Laboratories, LLC. - EIR, 2015-05-08
December, 2016 FDA 483 Barclay, Luke, & Pillai Specialty Pharmacy, PLLC - Form 483, 2016-12-20
March, 2016 FDA 483 Reliable Rexall-A Compounding Pharmacy - Form 483, 2016-04-20
June, 2016 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2016-06-17
February, 2019 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2019-02-05
June, 2016 EIR Intas Pharmaceuticals Limited - EIR, 2016-12-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more